首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >The Protective Effect of Sonneratia apetala Fruit Extract on Acetaminophen-Induced Liver Injury in Mice
【24h】

The Protective Effect of Sonneratia apetala Fruit Extract on Acetaminophen-Induced Liver Injury in Mice

机译:Sonneratia Apetala Fruit提取物对小鼠对乙酰氨基酚诱导的肝损伤的保护作用

获取原文
获取外文期刊封面目录资料

摘要

Acute liver injury is a common consequence of taking overdose of acetaminophen (APAP). The aim of this study was to evaluate the antioxidant activity and hepatoprotective effect of a mangrove plant Sonneratia apetala fruit extract (SAFE) on APAP-induced liver injury in mice. Mice were orally pretreated with SAFE (100, 200, and 400 mg/kg) daily for one week. The control and APAP groups were intragastrically administered with distilled water, and NAC group was treated with N-Acetyl-L-cysteine (NAC) before APAP exposure. The results manifested that SAFE significantly improved survival rates, attenuated hepatic histological damage, and decreased the alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in serum in APAP-exposed mice. SAFE treatment also increased glutathione (GSH) level and glutathione peroxidase (GSH-Px) activity, enhanced catalase (CAT), and total antioxidant capacity (T-AOC), as well as reducing malondialdehyde (MDA) level in liver. In addition, the formation of tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), and elevation of myeloperoxidase (MPO) in APAP-exposed mice were inhibited after SAFE treatment. And SAFE also displayed high DPPH radical scavenging activity and reducing power in vitro. The main bioactive components of SAFE such as total phenol, flavonoid, condensed tannin, and carbohydrate were determined. The current study proved that SAFE exerted potential protective effect against APAP-induced acute liver injury, which might be associated with the antioxidant and anti-inflammatory activities of SAFE.
机译:急性肝损伤是过量过量对乙酰氨基酚(APAP)的常见后果。该研究的目的是评估红树林植物Sonneratia Apetala果提取物(安全)对小鼠的APAP诱导的肝损伤的抗氧化活性和肝脏保护作用。每天用安全(100,200和400 mg / kg)对小鼠进行口服预处理一周。对照和APAP基团与蒸馏水胃内施用,在APAP暴露之前用N-乙酰基-1-半胱氨酸(NAC)处理NAC基团。结果表明,安全显着提高了存活率,减弱了肝脏组织学损伤,并在APAP暴露的小鼠中降低了血清中的丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平。安全处理还增加了谷胱甘肽(GSH)水平和谷胱甘肽过氧化物酶(GSH-PX)活性,增强的过氧化氢酶(CAT)和总抗氧化能力(T-AOC),以及还原肝脏中的丙二醛(MDA)水平。此外,在安全处理后抑制了肿瘤坏死因子-α(TNF-α),白细胞介素6(IL-6),白细胞介素6(IL-6)和髓过氧化物酶(MPO)的升高。安全也显示出高DPPH激进的清除活动和减少体外功率。确定安全的主要生物活性组分,如总酚,黄酮类化合物,凝结的单宁和碳水化合物。目前的研究证明,安全施加对APAP诱导的急性肝损伤的潜在保护作用,这可能与安全的抗氧化剂和抗炎活动有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号